145 related articles for article (PubMed ID: 38707870)
1. Identification and Economic Evaluation of Differentiated Thyroid Cancer Care Consumption Patterns Using Sequence Analysis.
Demeulemeester R; Grosclaude P; Grunenwald S; Saint-Pierre P; Savy N; Costa N
Int J Public Health; 2024; 69():1606664. PubMed ID: 38707870
[No Abstract] [Full Text] [Related]
2. Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective.
Lang BH; Wong CK; Chan CT
Eur J Surg Oncol; 2015 Jun; 41(6):758-65. PubMed ID: 25680952
[TBL] [Abstract][Full Text] [Related]
3. Attributable costs of differentiated thyroid cancer in the elderly Medicare population.
Boltz MM; Hollenbeak CS; Schaefer E; Goldenberg D; Saunders BD
Surgery; 2013 Dec; 154(6):1363-9; discussion 1369-70. PubMed ID: 23973115
[TBL] [Abstract][Full Text] [Related]
4. Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation.
Fleeman N; Houten R; Bagust A; Richardson M; Beale S; Boland A; Dundar Y; Greenhalgh J; Hounsome J; Duarte R; Shenoy A
Health Technol Assess; 2020 Jan; 24(2):1-180. PubMed ID: 31931920
[TBL] [Abstract][Full Text] [Related]
5. Dietary habits during the 2 months following the Chernobyl accident and differentiated thyroid cancer risk in a population-based case-control study.
Xhaard C; Rubino C; Souchard V; Maillard S; Ren Y; Borson-Chazot F; Sassolas G; Schvartz C; Colonna M; Lacour B; Woronoff AS; Velten M; Marrer E; Bailly L; Mariné Barjoan E; Schlumberger M; Drozdovitch V; Bouville A; Orgiazzi J; Adjadj E; de Vathaire F
Cancer Epidemiol; 2018 Feb; 52():142-147. PubMed ID: 29324353
[TBL] [Abstract][Full Text] [Related]
6. Annual financial impact of well-differentiated thyroid cancer care in the United States.
Lubitz CC; Kong CY; McMahon PM; Daniels GH; Chen Y; Economopoulos KP; Gazelle GS; Weinstein MC
Cancer; 2014 May; 120(9):1345-52. PubMed ID: 24481684
[TBL] [Abstract][Full Text] [Related]
7. Have 2006 ATA practice guidelines affected the treatment of differentiated thyroid cancer in the United States?
Goffredo P; Roman SA; Sosa JA
Thyroid; 2014 Mar; 24(3):463-71. PubMed ID: 23978295
[TBL] [Abstract][Full Text] [Related]
8. Differentiated thyroid cancer: millions spent with no tangible gain?
Furuya-Kanamori L; Sedrakyan A; Onitilo AA; Bagheri N; Glasziou P; Doi SAR
Endocr Relat Cancer; 2018 Jan; 25(1):51-57. PubMed ID: 29042396
[TBL] [Abstract][Full Text] [Related]
9. Cost Effectiveness of Lenvatinib, Sorafenib and Placebo in Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer.
Wilson L; Huang W; Chen L; Ting J; Cao V
Thyroid; 2017 Aug; 27(8):1043-1052. PubMed ID: 28486081
[TBL] [Abstract][Full Text] [Related]
10. Initial treatment patterns in younger adult patients with differentiated thyroid cancer in California.
Semrad TJ; Semrad AM; Farwell DG; Chen Y; Cress R
Thyroid; 2015 May; 25(5):509-13. PubMed ID: 25744759
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Differentiated Thyroid Carcinomas in French Polynesia After Atmospheric Nuclear Tests Performed by France.
de Vathaire F; Zidane M; Xhaard C; Souchard V; Chevillard S; Ory C; Rachédi F; Nunez S; Leufroy A; Noël L; Guérin T; Shan L; Bost-Bezeaud F; Petitdier P; Soubiran G; Allodji R; Ren Y; Doyon F; Taquet M; Gardon J; Bouville A; Drozdovitch V
JAMA Netw Open; 2023 May; 6(5):e2311908. PubMed ID: 37145599
[TBL] [Abstract][Full Text] [Related]
12. Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
Grani G; Zatelli MC; Alfò M; Montesano T; Torlontano M; Morelli S; Deandrea M; Antonelli A; Francese C; Ceresini G; Orlandi F; Maniglia CA; Bruno R; Monti S; Santaguida MG; Repaci A; Tallini G; Fugazzola L; Monzani F; Giubbini R; Rossetto R; Mian C; Crescenzi A; Tumino D; Pagano L; Pezzullo L; Lombardi CP; Arvat E; Petrone L; Castagna MG; Spiazzi G; Salvatore D; Meringolo D; Solaroli E; Monari F; Magri F; Triggiani V; Castello R; Piazza C; Rossi R; Ferraro Petrillo U; Filetti S; Durante C
Thyroid; 2021 Feb; 31(2):264-271. PubMed ID: 32475305
[No Abstract] [Full Text] [Related]
13. In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013.
Maroun R; Maunoury F; Benjamin L; Nachbaur G; Durand-Zaleski I
PLoS One; 2016; 11(9):e0162864. PubMed ID: 27649305
[TBL] [Abstract][Full Text] [Related]
14. [Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
Melliere D; Hindie E; Becquemin JP; Desgranges P; Allaire E; Geachan E
Bull Acad Natl Med; 2006 Jan; 190(1):89-106; discussion 106-9. PubMed ID: 16878448
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic factors and the presentation, management, and outcome of patients with differentiated thyroid carcinoma.
Ghori FY; Gutterman-Litofsky DR; Jamal A; Yeung SC; Arem R; Sherman SI
Thyroid; 2002 Nov; 12(11):1009-16. PubMed ID: 12490079
[TBL] [Abstract][Full Text] [Related]
16. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
Kelly A; Barres B; Kwiatkowski F; Batisse-Lignier M; Aubert B; Valla C; Somda F; Cachin F; Tauveron I; Maqdasy S
PLoS One; 2019; 14(8):e0221298. PubMed ID: 31425569
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
18. Disease-Specific Survival Trends for Patients Presenting with Differentiated Thyroid Cancer and Distant Metastases in the United States, 1992-2018.
Wilhelm A; Conroy PC; Calthorpe L; Shui AM; Kitahara CM; Roman SA; Sosa JA
Thyroid; 2023 Jan; 33(1):63-73. PubMed ID: 36413032
[No Abstract] [Full Text] [Related]
19. Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen.
Borget I; Remy H; Chevalier J; Ricard M; Allyn M; Schlumberger M; De Pouvourville G
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1457-63. PubMed ID: 18385999
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
